Cargando…

The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome

Breast cancer is a disease of genomic alterations, of which the panorama of somatic mutations and how these relate to subtypes and therapy response is incompletely understood. Within SCAN‐B (ClinicalTrials.gov: NCT02306096), a prospective study elucidating the transcriptomic profiles for thousands o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brueffer, Christian, Gladchuk, Sergii, Winter, Christof, Vallon‐Christersson, Johan, Hegardt, Cecilia, Häkkinen, Jari, George, Anthony M, Chen, Yilun, Ehinger, Anna, Larsson, Christer, Loman, Niklas, Malmberg, Martin, Rydén, Lisa, Borg, Åke, Saal, Lao H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539222/ https://www.ncbi.nlm.nih.gov/pubmed/32926574 http://dx.doi.org/10.15252/emmm.202012118

Ejemplares similares

Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
por: Dahlgren, Malin, et al.
Publicado: (2021)

Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
por: Brueffer, Christian, et al.
Publicado: (2018)

The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
por: Saal, Lao H, et al.
Publicado: (2015)

Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
por: Larsson, Christer, et al.
Publicado: (2020)

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
por: Vallon-Christersson, Johan, et al.
Publicado: (2019)

Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative
por: Rydén, L., et al.
Publicado: (2018)

How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
por: Saghir, Hani, et al.
Publicado: (2022)

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
por: Lundgren, Christine, et al.
Publicado: (2019)

Refinement of breast cancer molecular classification by miRNA expression profiles
por: Søkilde, Rolf, et al.
Publicado: (2019)

Whole-genome-sequencing of triple negative breast cancers in a population-based clinical study
por: Staaf, Johan, et al.
Publicado: (2019)

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
por: Glodzik, Dominik, et al.
Publicado: (2020)

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
por: Staaf, Johan, et al.
Publicado: (2022)

Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
por: Demircan, Kamil, et al.
Publicado: (2023)

Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors
por: Dalal, Hina, et al.
Publicado: (2022)

Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
por: Bengtsson, Ylva, et al.
Publicado: (2023)

Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
por: Winter, C., et al.
Publicado: (2016)

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
por: Förnvik, Daniel, et al.
Publicado: (2019)

Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study: experiences from re-contacting mutation carriers and relatives
por: Nilsson, Martin P., et al.
Publicado: (2017)

Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study
por: Demircan, Kamil, et al.
Publicado: (2021)

Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing
por: Alkner, Sara, et al.
Publicado: (2015)

Autoimmunity to selenoprotein P predicts breast cancer recurrence
por: Demircan, Kamil, et al.
Publicado: (2022)

BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data
por: Saal, Lao H, et al.
Publicado: (2002)

Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017)

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
por: Olsson, Eleonor, et al.
Publicado: (2011)

Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing
por: Tang, Man-Hung Eric, et al.
Publicado: (2015)

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
por: Holm, Karolina, et al.
Publicado: (2010)

BASE - 2nd generation software for microarray data management and analysis
por: Vallon-Christersson, Johan, et al.
Publicado: (2009)

Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer
por: Olsson, Eleonor, et al.
Publicado: (2015)

Regulatory networks and 5′ partner usage of miRNA host gene fusions in breast cancer
por: Hafstað, Völundur, et al.
Publicado: (2022)

TopHat-Recondition: a post-processor for TopHat unmapped reads
por: Brueffer, Christian, et al.
Publicado: (2016)

Frequent miRNA-convergent fusion gene events in breast cancer
por: Persson, Helena, et al.
Publicado: (2017)

The CD44(+)/CD24(- )phenotype is enriched in basal-like breast tumors
por: Honeth, Gabriella, et al.
Publicado: (2008)

Non-coding antisense transcription detected by conventional and single-stranded cDNA microarray
por: Vallon-Christersson, Johan, et al.
Publicado: (2007)

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
por: Olsson, Eleonor, et al.
Publicado: (2015)

High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer
por: Staaf, Johan, et al.
Publicado: (2010)

Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery
por: Mosquim Junior, Sergio, et al.
Publicado: (2022)

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
por: Jönsson, Göran, et al.
Publicado: (2010)

Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study
por: Nacer, Deborah F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vgkpnh1g0qshhpcosro89a4oir